ClinicalTrials.gg
Not yet recruitingNCT07178899Updated Jun 2, 2026

Designing a Smoking Intervention for Youth Smokers

An interventional study of typology-based intervention and Routine Treatment in Smoking (Tobacco) Addiction, Young Adult and RCT, sponsored by The University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged Up to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
Up to 25 Years
Sex
All
01

Study summary

This study aims to develop a typology-based intervention delivered by smoking cessation (SC) counsellors to prevent smoking relapse in ex-smokers who recently quit. The two main research questions include (1) Can a typology-based smoking relapse prevention intervention be feasible and accepted by the smokers and SC counsellors who deliver the new intervention? (2) What is the preliminary evidence on the efficacy of the typology-based smoking relapse prevention to increase tobacco abstinence in ex-smokers who have recently quit? If the intervention shows at least a small effect size (i.e. risk ratio>1.3), or the intervention is feasible while modifications can potentially increase the efficacy, a future definitive RCT is warranted.

Read the detailed description

Phase 1 Q-method outcomes The outcomes of Phase 1 of this study will be Q-sorts completed by participants which will be inter-correlated producing a matrix for factor rotation and automatic flagging, and the z-score and the factor of the Q-sorts will be calculated.

The tobacco epidemic remains a pressing global health challenge, with tobacco-related illness contributing significantly to a high death rate worldwide. Smoking is the predominant mode of tobacco consumption worldwide and serves as the driving force behind this epidemic. According to the World Health Organization, there are an estimated 1.3 billion tobacco users worldwide currently. In Hong Kong, the smoking rate is estimated to be around 9.5%, with approximately 580 000 daily smokers in 2021. Despite the rate has decreased significantly from 23.3% in 1982, the Hong Kong government aims to further reduce the prevalence from 9.5% to 7.8% in 2025. The high prevalence of smoking imposes a significant public health burden worldwide, with tobacco use killing up to 50% of its users. Additionally, smoking causes cancers, stroke, cardiovascular diseases and respiratory diseases, with around 7000 deaths reported each year. One approach to reduce the smoking prevalence is to promote smoking cessation (SC) treatment among current smokers.

Young smokers constitute a large cohort of new smokers every year. It is estimated that up to 90% of daily smokers first tried smoking before 18 years old. Published studies consistently highlight the concerning prevalence of youth smoking within Hong Kong's community. Data from the recent school survey highlighted that despite only 1.2% of secondary school engages in smoking, a significant portion (7.4%, equivalent to around 24 000 students) of the youth population have previously engaged in smoking behaviour. The rate of youth ever smokers remain high at 7.4% in Hong Kong, equivalent to approximately 24 000 secondary school students, suggesting that youths are eagerly experimenting. This is also evident in the high prevalence of youths trying other tobacco products such as e-cigarettes or heated tobacco products, from 57.4% (178/310) in 2017 to 2018 to 85.9% (243/283) in 2019 to 2020. The shift from occasional smoking to dependency in youth is a crucial stage, making the adolescent years a key period for understanding and addressing smoking behaviours. It represents a key window for targeted interventions to prevent the progression towards regular smoking habits.

Smoking imposes severe health risks and long-term consequences. Effects of tobacco are well demonstrated including the effects of nicotine on brain development. The prevalence of tobacco use among youths not only jeopardizes their immediate health but negatively impacts their future well-being. Moreover, observations from Hong Kong further emphasize the pressing need for effective SC initiatives tailored to the unique needs of youths. The multifaceted challenges such as peer pressure and social influences are faced by struggling youths.

In response to these identified needs, it is imperative to develop comprehensive youth-orientated SC programs that encompass various aspects of prevention, intervention and support. Evidence-based strategies such as counselling services have shown promising outcomes in promoting smoke-free lifestyles among youths. Additionally, collaborations among healthcare institutions, government agencies and community organizations are crucial for maximizing the reach and effectiveness of cessation efforts. By addressing the health needs of local community through targeted youth SC initiatives, the investigators can significantly mitigate the adverse health effects of tobacco use among Hong Kong's young population.

Phase 3 Randomized control trial outcomes The primary outcomes of Phase 3 of this study will be smokers' (1) self-reported abstinence in the past 30 days at 2-month follow-up; (2) iScreen OFD Cotinine Saliva Test Kit (\<30ng/ml) biochemical validated tobacco abstinence; (3) the difference of the feasibility and acceptability score of the typology-based intervention between the intervention and control group.

02

Conditions studied

  • Smoking (Tobacco) Addiction
  • Young Adult
  • RCT

Keywords

  • Smoking Cessation
  • Young Adult
  • RCT
03

In context

Smoking

1,509 studies on the registry are indexed under Smoking; 193 are open to participants now.

This study's planned enrollment of 100 is below the median of 115 across 1,164 interventional studies indexed under Smoking.

Browse Smoking studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,292 studies on the registry; 348 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (Phase 1):

  • Hong Kong citizens
  • Have ever habitually used conventional cigarettes in the past year
  • Not using cigarettes for the past 7-30 days
  • Aged 25 or below (parental consent is required for participants under 18 years old)
  • No barriers in communicating in Cantonese and reading and writing Chinese
  • Quit smoking without using cessation services

Inclusion Criteria (Phase 3):

  • Hong Kong citizens
  • Have ever habitually used conventional cigarettes in the past year
  • Received at least 4 weeks of smoking cessation service before enrolling into the study
  • abstained from tobacco use for 7 days without concurrent use of any cessation services
  • Aged 25 or below (parental consent is required for participants under 18 years old)
  • No barriers in communicating in Cantonese and reading and writing Chinese

Exclusion Criteria (Phase 1 \& 3):

  • Have unstable physical or psychological conditions as advised by doctors or counsellors
  • Are users of illicit drugs (e.g., heroin, marijuana, ketamine, etc.)
  • Have become pregnant in the past two months
  • unable to communicate in Cantonese and read Chinese

Inclusion Criteria (Phase 2) (for SC counsellors) :

  • SC counsellors from local SC clinics under HKU Youth Quit Line, Tung Wah Group of Hospitals Integrated Center on Smoking Cessation and United Christian Nethersole Community Health Service
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Typology-based Intervention (Intervention group)

    In the Typology-based intervention group, in addition to routine counselling, counsellors will apply typological counselling protocol for the participants. The counselling protocol includes 12 distinguishing statement in Q-methodology. Counsellor will discuss these statements with participants and collect their viewpoints on these statements. After the counselling session, participant can chat with the AI chatbot in WhatsApp for 30 days. The chatbot is specially designed and able to read the content of typological counselling of each participant and provide instant response. In addition to incoming message, the AI chatbot will sent personalized e-messages automatically to encourage participants to engage in discussion with chatbot. The frequency of messages will be one message per week, total 4 for 4 weeks.

    Behavioral: typology-based intervention

  • Active comparator
    Routine Treatment (Control Group)

    In the Routine Treatment group, the routine smoking cessation counselling, including generic advice on preventing smoking relapse, will be retained.

    Behavioral: Routine Treatment

Interventions

  • Behavioraltypology-based intervention

    The typology-based intervention includes: (1) a typology-based counselling, (2) instant response from a specially designed AI Chatbot for 30 days (3) Chatbot initiated AI message for 4 weeks (one message per week). All interventions and materials are delivered by smoking counselling.

  • BehavioralRoutine Treatment

    The routine smoking cessation intervention includes: (1) Routine counselling generic advice on preventing smoking relapse

06

What researchers measure

Primary outcomes

  1. self-reported abstinence in the past 30 days at 2-month follow-up

    Time frame: 2 mouths

  2. iScreen OFD Cotinine Saliva Test Kit (<30ng/ml) biochemical validated tobacco abstinence

    Participants who report tobacco abstinence will be invited for a biochemical validation to test if his/her saliva cotinine is less than 30ng/ml measured by the iScreen OFD Cotinine Saliva Test Kit.

    Time frame: 2 months

  3. the difference of the feasibility and acceptability score of the typology-based intervention between the intervention and control group.

    The investigators will have 4 feasibility questions and 4 appropriateness questions for counsellor to answer from 1 (Completely disagree) to 5 (Completely agree). Also, the investigators will have 4 acceptability questions for ex-smokers to answer. The investigators would like to observe if there is a difference between the intervention group and the control group

    Time frame: 2 months

Secondary outcomes

  1. Time required for the counselling

    The average time required for the typological counselling in minutes

    Time frame: End of all follow-up (approximately 6 month)

  2. Compliance rate of the SC counsellors in following the intervention protocol

    There were 26 questions in the counselling protocol. SC counsellors have to record the number of questions asked during the typological counselling. The rate is calculated by "number of questions asked"/26

    Time frame: End of all follow-up (approximately 6 month)

  3. Proportion of screened clients who participate in the RCT

    The proportion is calculated by "Number of enrolled participants" / "Total number of participant screened"

    Time frame: End of all follow-up (approximately 6 month)

  4. Dropout rate of the participants who consent to the RCT

    The dropout rate is calculated by "Number of participants dropout from study" / "Total number of enrolled participant"

    Time frame: End of all follow-up (approximately 6 month)

  5. Satisfaction on the SC counsellors

    Satisfaction on the SC counsellors is measured by a 5 point Likert scale reported by the enrolled participants, from 1: Very Dissatisfied to 5: Very Satisfied.

    Time frame: 2 months

  6. Satisfaction on the AI chatbot and the chatbot initiated e-messages

    Satisfaction on AI chatbot and the chatbot initiated is measured by a 10 point Likert scale reported by the enrolled participants, from 1: Very Dissatisfied to 10: Very Satisfied.

    Time frame: 2 months

  7. Frequency of reading the chatbot initiated e-messages

    The Frequency of reading the e-messages is measured by 5 point Likert scale, that indicate the number of e-messages that the participant had read, from 1 (indicate the participant had read none of the e-messages), to 5 (indicate the participant had read all of the e-messages).

    Time frame: 2 months

  8. Perceived effectiveness on the intervention

    The perceived effectiveness on the intervention is measured by a 10 point likert scale. Participant will rate the usefulness of the intervention received in helping them to maintain smoking abstinence (10: Very useful \| 0: Useless).

    Time frame: 2 months

  9. Satisfaction on the enrolment procedures

    Satisfaction on the enrolment procedures is measured by a 10 point Likert scale reported by the participants (0: The enrollment procedure is slow and complicated \| 10: the enrollment procedure is fast and simple).

    Time frame: 2 months

  10. Intention to recommend the intervention to other smokers

    Intention to recommend the intervention to other smokers is measured by a 10 point Likert scale, 10: strongly recommended to other smokers \| 0: not recommended to other smoker

    Time frame: 2 months

  11. Satisfaction about the intervention from SC counsellor

    Satisfaction about the intervention from SC counsellor is measured by a 5 point Likert scale. SC counsellor will rate the effectiveness of the typological counselling in helping their client to quit smoking, from 1: very ineffective to 5: very effective.

    Time frame: End of all follow-up (approximately 6 month)

  12. Perceived appropriateness of the intervention length from SC counsellor

    The perceived appropriateness of the intervention length from SC counsellor is measured by a 5 point Likert scale. SC counsellor will be asked if they agreed that the length of the typological counselling is suitable for their client, from 1 strongly disagree to 5 strongly agree.

    Time frame: End of all follow-up (approximately 6 month)

  13. Satisfaction on the enrolment and counselling procedures from SC counsellors

    The satisfaction on the enrolment procedures from SC counsellors is measured by a 5 point Likert scale. Counsellors will be asked if they agreed that enrolment and counselling procedures is simple and could be easily done in the SC clinics, from 1: strongly disagree to 5: strongly agree.

    Time frame: End of all follow-up (approximately 6 month)

  14. Perceived effectiveness of the counselling protocol from SC counsellor

    The perceived effectiveness of the counselling protocol from SC counsellor is measured by a 5 point Likert scale. SC counsellor will be asked if they agreed that the typological intervention can help them screen out smokers who are prone to relapse, from 1: strongly disagree to 5: strongly agree.

    Time frame: End of all follow-up (approximately 6 month)

  15. Perceived clients' acceptance of the intervention from SC counsellor

    The Perceived clients' acceptance of the intervention from SC counsellor is measured by a 5 point Likert scale. Participants are asked if they agreed that counselling content provided the SC counselling gain their trust and acceptance, from 1: strongly disagree to 5: strongly agree.

    Time frame: 2 months

  16. Intention to apply this intervention in other clients from SC counsellors

    Intention to apply this intervention in other clients from SC counsellors is measured by a 5 point Likert scale. SC counsellors are asked if they want to apply the typological intervention to other clients in future, from 1: SC counsellors will not apply it to their client in the future, to 5: SC counsellors want to apply it their client in the future.

    Time frame: End of all follow-up (approximately 6 month)

07

Study locations

1 site
08

References and documents

Publications

  • Zabala A, Pascual U. Bootstrapping Q Methodology to Improve the Understanding of Human Perspectives. PLoS One. 2016 Feb 4;11(2):e0148087. doi: 10.1371/journal.pone.0148087. eCollection 2016. PubMed 26845694 ↗
  • Watts S, Stenner P. Doing the fieldwork: participants, materials and procedure. 2012 2022/03/11. In: Doing Q Methodological Research: Theory, Method and Interpretation . London: SAGE Publications Ltd
  • Karpinski JP, Timpe EM, Lubsch L. Smoking cessation treatment for adolescents. J Pediatr Pharmacol Ther. 2010 Oct;15(4):249-63. PubMed 22477813 ↗
  • Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000. PubMed 22248234 ↗
  • Duncan Millar J, Mason H, Kidd L. What is Q methodology? Evid Based Nurs. 2022 Jul;25(3):77-78. doi: 10.1136/ebnurs-2022-103568. Epub 2022 May 24. No abstract available. PubMed 35609957 ↗
  • Bowen NK, Lee JS, Weller BE. SOCIAL ENVIRONMENTAL RISK AND PROTECTION: A TYPOLOGY WITH IMPLICATIONS FOR PRACTICE IN ELEMENTARY SCHOOLS. Child Sch. 2007;29(4):229-242. doi: 10.1093/cs/29.4.229. PubMed 21709821 ↗
  • Tombor I, Shahab L, Herbec A, Neale J, Michie S, West R. Smoker identity and its potential role in young adults' smoking behavior: A meta-ethnography. Health Psychol. 2015 Oct;34(10):992-1003. doi: 10.1037/hea0000191. Epub 2015 Jan 26. PubMed 25622078 ↗
  • Jarvelaid M. Adolescent tobacco smoking and associated psychosocial health risk factors. Scand J Prim Health Care. 2004 Mar;22(1):50-3. doi: 10.1080/02813430310000988. PubMed 15119521 ↗
  • Tombor I, Vangeli E, West R, Shahab L. Progression towards smoking cessation: Qualitative analysis of successful, unsuccessful, and never quitters. J Subst Use. 2017 Oct 5;23(2):214-222. doi: 10.1080/14659891.2017.1378746. eCollection 2018. PubMed 29527597 ↗
  • Rose JS, Chassin L, Presson C, Sherman SJ, Stein MD, Col N. A latent class typology of young women smokers. Addiction. 2007 Aug;102(8):1310-9. doi: 10.1111/j.1360-0443.2007.01889.x. PubMed 17624981 ↗
  • Thomas JL, Luo X, Bengtson J, Wang Q, Ghidei W, Nyman J, Lust K, An L, Wetter DW, Epstein L, Ahluwalia JS. Enhancing Quit & Win contests to improve cessation among college smokers: a randomized clinical trial. Addiction. 2016 Feb;111(2):331-9. doi: 10.1111/add.13144. Epub 2015 Nov 11. PubMed 26767340 ↗
  • Villanti AC, West JC, Klemperer EM, Graham AL, Mays D, Mermelstein RJ, Higgins ST. Smoking-Cessation Interventions for U.S. Young Adults: Updated Systematic Review. Am J Prev Med. 2020 Jul;59(1):123-136. doi: 10.1016/j.amepre.2020.01.021. Epub 2020 May 14. PubMed 32418800 ↗
  • Chaiton M, Diemert L, Cohen JE, Bondy SJ, Selby P, Philipneri A, Schwartz R. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016 Jun 9;6(6):e011045. doi: 10.1136/bmjopen-2016-011045. PubMed 27288378 ↗
  • Rosa JD, Aloise-Young P. A Qualitative Study of Smoker Identity Among College Student Smokers. Subst Use Misuse. 2015;50(12):1510-7. doi: 10.3109/10826084.2015.1018549. Epub 2015 Nov 19. PubMed 26584272 ↗
  • Davey, G. and Zhao, X. (2020), Turning Points to Becoming a Tobacco Smoker: Smoking Initiation and Identity Change among Chinese Youth. Symbolic Interaction, 43: 308-331
  • Bitar S, Collonnaz M, O'Loughlin J, Kestens Y, Ricci L, Martini H, Agrinier N, Minary L. A Systematic Review of Qualitative Studies on Factors Associated With Smoking Cessation Among Adolescents and Young Adults. Nicotine Tob Res. 2024 Jan 1;26(1):2-11. doi: 10.1093/ntr/ntad167. PubMed 37648287 ↗
  • Barrington-Trimis JL, Braymiller JL, Unger JB, McConnell R, Stokes A, Leventhal AM, Sargent JD, Samet JM, Goodwin RD. Trends in the Age of Cigarette Smoking Initiation Among Young Adults in the US From 2002 to 2018. JAMA Netw Open. 2020 Oct 1;3(10):e2019022. doi: 10.1001/jamanetworkopen.2020.19022. PubMed 33021650 ↗
  • An LC, Klatt C, Perry CL, Lein EB, Hennrikus DJ, Pallonen UE, Bliss RL, Lando HA, Farley DM, Ahluwalia JS, Ehlinger EP. The RealU online cessation intervention for college smokers: a randomized controlled trial. Prev Med. 2008 Aug;47(2):194-9. doi: 10.1016/j.ypmed.2008.04.011. Epub 2008 May 2. PubMed 18565577 ↗
  • Cho ER, Brill IK, Gram IT, Brown PE, Jha P. Smoking Cessation and Short- and Longer-Term Mortality. NEJM Evid. 2024 Mar;3(3):EVIDoa2300272. doi: 10.1056/EVIDoa2300272. Epub 2024 Feb 8. PubMed 38329816 ↗
  • Li WHC, Chan SSC, Wang MP, Ho KY, Cheung YTY, Chan VWF, Lam TH. An Evaluation of the Youth Quitline Service Young Hong Kong Smokers. J Adolesc Health. 2017 May;60(5):584-591. doi: 10.1016/j.jadohealth.2016.11.022. Epub 2017 Jan 19. PubMed 28111012 ↗
  • Ho SY, Chen J, Leung LT, Mok HY, Wang L, Wang MP, Lam TH. Adolescent Smoking in Hong Kong: Prevalence, Psychosocial Correlates, and Prevention. J Adolesc Health. 2019 Jun;64(6S):S19-S27. doi: 10.1016/j.jadohealth.2019.01.003. PubMed 31122545 ↗
  • McClure LA, Arheart KL, Lee DJ, Sly DF, Dietz NA. Young adult former ever smokers: the role of type of smoker, quit attempts, quit aids, attitudes/beliefs, and demographics. Prev Med. 2013 Nov;57(5):690-5. doi: 10.1016/j.ypmed.2013.08.028. Epub 2013 Sep 8. PubMed 24021991 ↗
  • Goriounova NA, Mansvelder HD. Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a012120. doi: 10.1101/cshperspect.a012120. PubMed 22983224 ↗
  • School of Public Health of the University of Hong Kong. School-based survey on smoking among students in 2020/21.
  • US Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.
  • Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of Tobacco Smoking: A Review. JAMA. 2022 Feb 8;327(6):566-577. doi: 10.1001/jama.2022.0395. PubMed 35133411 ↗
  • World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019: Offer help to quit tobacco use. Geneva: World Health Organization; 2019
  • McGhee SM, Ho LM, Lapsley HM, Chau J, Cheung WL, Ho SY, Pow M, Lam TH, Hedley AJ. Cost of tobacco-related diseases, including passive smoking, in Hong Kong. Tob Control. 2006 Apr;15(2):125-30. doi: 10.1136/tc.2005.013292. PubMed 16565461 ↗

Individual participant data

Plan to share: Yes — Research data and documentation will be available upon request

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: 3 years after the completion of the relevant publications

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07178899
Responsible party
CHEUNG, Cara Hor Yine (Post Doctoral Fellow, The University of Hong Kong) — Principal investigator
First posted
Sep 17, 2025
Start date
Jun 5, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Jun 2, 2026

Study contacts

Cara Hor Yine Cheung, Dr.
Contact
chycheun@hku.hk
+852 39103198

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion